1. Home
  2. BDSX vs CPHC Comparison

BDSX vs CPHC Comparison

Compare BDSX & CPHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDSX
  • CPHC
  • Stock Information
  • Founded
  • BDSX 2005
  • CPHC 1994
  • Country
  • BDSX United States
  • CPHC United States
  • Employees
  • BDSX N/A
  • CPHC N/A
  • Industry
  • BDSX Precision Instruments
  • CPHC Services-Misc. Amusement & Recreation
  • Sector
  • BDSX Health Care
  • CPHC Consumer Discretionary
  • Exchange
  • BDSX Nasdaq
  • CPHC Nasdaq
  • Market Cap
  • BDSX 115.4M
  • CPHC 102.1M
  • IPO Year
  • BDSX 2020
  • CPHC 1994
  • Fundamental
  • Price
  • BDSX $0.61
  • CPHC $18.50
  • Analyst Decision
  • BDSX Strong Buy
  • CPHC
  • Analyst Count
  • BDSX 3
  • CPHC 0
  • Target Price
  • BDSX $2.93
  • CPHC N/A
  • AVG Volume (30 Days)
  • BDSX 276.1K
  • CPHC 1.7K
  • Earning Date
  • BDSX 05-07-2025
  • CPHC 05-08-2025
  • Dividend Yield
  • BDSX N/A
  • CPHC 1.53%
  • EPS Growth
  • BDSX N/A
  • CPHC N/A
  • EPS
  • BDSX N/A
  • CPHC 0.42
  • Revenue
  • BDSX $71,323,000.00
  • CPHC $61,562,288.00
  • Revenue This Year
  • BDSX $32.90
  • CPHC N/A
  • Revenue Next Year
  • BDSX $24.65
  • CPHC N/A
  • P/E Ratio
  • BDSX N/A
  • CPHC $43.45
  • Revenue Growth
  • BDSX 45.30
  • CPHC 0.20
  • 52 Week Low
  • BDSX $0.59
  • CPHC $18.00
  • 52 Week High
  • BDSX $2.04
  • CPHC $24.78
  • Technical
  • Relative Strength Index (RSI)
  • BDSX 33.15
  • CPHC 35.98
  • Support Level
  • BDSX $0.63
  • CPHC $18.00
  • Resistance Level
  • BDSX $0.78
  • CPHC $19.01
  • Average True Range (ATR)
  • BDSX 0.07
  • CPHC 0.24
  • MACD
  • BDSX -0.01
  • CPHC -0.05
  • Stochastic Oscillator
  • BDSX 9.13
  • CPHC 33.33

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

About CPHC Canterbury Park Holding Corporation 'New'

Canterbury Park Holding Corp is in the business of pari-mutuel wagering on horse races and unbanked card games at its canterbury park racetrack and card casino facility in Minnesota. The company has four operating segments. The horse racing segment represents pari-mutuel wagering operations on simulcast and lives horse races; the Casino segment represents unbanked card operations; the food and beverage segment includes concessions, catering, and events services provided at the Racetrack; and the development segment represents its real estate development operations. The firm generates a majority of its revenue from the Casino segment.

Share on Social Networks: